Electra Therapeutics Inc.
Clinical trials sponsored by Electra Therapeutics Inc., explained in plain language.
-
New hope for tough blood cancers: first human trial begins
Disease control Recruiting nowThis is the first human study of an experimental drug called ELA026 for adults with T cell or NK cell cancers that have returned or stopped responding to other treatments. The study aims to find safe doses and see if the drug can help control the cancer. It will enroll about 84 p…
Phase: PHASE1 • Sponsor: Electra Therapeutics Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New antibody targets deadly immune storm in rare disease
Disease control Recruiting nowThis study is testing an investigational drug called ELA026 for people with secondary hemophagocytic lymphohistiocytosis (sHLH), a rare and life-threatening condition where the immune system becomes dangerously overactive. The main goals are to see if ELA026 is safe, if it can he…
Phase: PHASE2, PHASE3 • Sponsor: Electra Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC